|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.80 EUR | +1.20% |
|
+8.59% | -7.40% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.64% | 1.99% | 20.13x | 4.03x | 3.88x | 15.28x | 18.27x | 3.42B | ||
| 0.57% | 0.63% | 35.7x | 21.69x | 12.68x | 26.75x | 27.72x | 1,067B | ||
| 2.04% | 2.14% | 28.24x | 7.17x | 6.45x | 17.87x | 19.41x | 635B | ||
| 2.65% | 2.79% | 33.87x | 12909.91x | 7.65x | 15.73x | 16.24x | 458B | ||
| 2.82% | 2.88% | 19.22x | 7.19x | 4.69x | 11.57x | 12.98x | 347B | ||
| 2.81% | 2.94% | 21.56x | 6.22x | 5.71x | 14.24x | 15.08x | 295B | ||
| 1.98% | 2.08% | 21.1x | 4.94x | 4.45x | 12.31x | 13.31x | 262B | ||
| 3.54% | 3.45% | 14.14x | 6.24x | 5.26x | 10.84x | 12.75x | 216B | ||
| 2.68% | 2.83% | 24.66x | 18.97x | 6.48x | 11.43x | 14.83x | 203B | ||
| 2.55% | 2.64% | -46.58x | 8.17x | 5.59x | 30.88x | 61.57x | 161B | ||
| 7.02% | 7.08% | 12.46x | 1.59x | 3.06x | 7.75x | 8.76x | 140B | ||
| 4.06% | 4.14% | 12.06x | 5.45x | 3.28x | 8.85x | 9.51x | 127B | ||
| -.--% | -.--% | 27.21x | 5.47x | 8.23x | 18.55x | 19.44x | 121B | ||
| 5.6% | 5.92% | 11.44x | 1.21x | 2.16x | 6.92x | 7.86x | 104B | ||
| 3.63% | 3.81% | 12.1x | 4.42x | 2.71x | 7.84x | 8.96x | 102B | ||
| 1.84% | 2.12% | 24.15x | 5.43x | 8.05x | 15.24x | 15.99x | 74.54B | ||
| 3.62% | 3.7% | 45.97x | 1.22x | 2.77x | 9.8x | 28.48x | 55.09B | ||
| 0.5% | 0.56% | 38.33x | 5.12x | 8.65x | 28.71x | 30.01x | 52.08B | ||
| 0.49% | 1.37% | 19.91x | 1.61x | 1.69x | 8.02x | 13.47x | 51.52B | ||
| Average | 2.63% | 2.79% | 19.77x | 685.58x | 5.45x | 14.66x | 18.67x | 235.45B | |
| Weighted average by Cap. | 2.23% | 2.34% | 23.93x | 1,331.97x | 7.29x | 17.38x | 19.90x |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















